Ubs Oconnor LLC Legend Biotech Corp Transaction History
Ubs Oconnor LLC
- $1.51 Billion
- Q4 2024
A detailed history of Ubs Oconnor LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Ubs Oconnor LLC holds 20,000 shares of LEGN stock, worth $744,000. This represents 0.04% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$744,000% of portfolio
0.04%Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
233Shares Held
86.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$279 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$253 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$223 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$213 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$213 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.23B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...